Literature DB >> 3698007

Effect of sidestream and mainstream smoke exposure on in vitro interferon-alpha/beta production by L-929 cells.

G Sonnenfeld, R W Hudgens.   

Abstract

A peristaltic pump smoking machine that allows simultaneous generation of mainstream (active) and sidestream (passive) smoke from a cigarette was used to expose cultures of murine L-929 cells, a potent producer of interferon, to smoke. The cigarette used was the University of Kentucky 2R1 reference cigarette. The dosages of smoke used for exposure were the highest doses possible that generated a minimum toxic effect, and they were serially diluted to lower doses. Dosages were determined by the number of smoke puffs generated, the volume of smoke puffs generated, and the total particulate matter deposited on Cambridge filters in the smoke machine. Viability of exposed cells was equivalent to control cell cultures. Interferon-alpha/beta was induced by addition of polyriboinosinic-polyribocytidylic acid to the cells. Interferon production was substantially reduced in viable cells exposed to mainstream or sidestream smoke. Aging of smoke by delaying time of exposure of the cells to the smoke, or filtration of smoke through activated charcoal substantially decreased the alteration of interferon production by smoke exposure. These results suggest that actual exposure of cells to mainstream or sidestream smoke can inhibit in vitro interferon-alpha/beta induction, but the cells can be protected from these effects by smoke manipulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698007

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

Review 1.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

2.  Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptor.

Authors:  Wei-Chun HuangFu; Jianghuai Liu; Ronald N Harty; Serge Y Fuchs
Journal:  FEBS Lett       Date:  2008-08-21       Impact factor: 4.124

Review 3.  Viruses exacerbating chronic pulmonary disease: the role of immune modulation.

Authors:  Aran Singanayagam; Priya V Joshi; Patrick Mallia; Sebastian L Johnston
Journal:  BMC Med       Date:  2012-03-15       Impact factor: 8.775

Review 4.  Respiratory Viruses and Asthma.

Authors:  Peter A B Wark; James Michael Ramsahai; Prabuddha Pathinayake; Bilal Malik; Nathan W Bartlett
Journal:  Semin Respir Crit Care Med       Date:  2018-02-10       Impact factor: 3.119

Review 5.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.